Press "Enter" to skip to content

AstraZeneca challenges Roche on frontline SCLC after seizing an interim win — and Merck may not be far behind – Endpoints News

admin 0

AstraZeneca challenges Roche on frontline SCLC after seizing an interim win — and Merck may not be far behind  Endpoints News

“This is the first trial offering the flexibility of combining immunotherapy with different platinum-based regimens in small cell lung cancer, expanding treatment …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *